Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Renal Cell 10Kidney Neoplasms 9Neuroblastoma 4Melanoma 4Leukemia 2Breast Neoplasms 2Uveal Melanoma 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Intestinal Neoplasms 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1

Interventions

Vincristine 2Radiotherapy 2Melphalan 2Ifosfamide 2Etoposide 2Doxorubicin 2Dactinomycin 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1aldesleukin 1Methylprednisolone 1Mesna 1Magnetic Resonance Spectroscopy 1Gene Expression Profiling 1Gelclair 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive, Peripheral × aldesleukin × Clear all
NCT00101309 2013-12-18

Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Unknown
10 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡